{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T16:05:36Z","timestamp":1794672336595,"version":"4.9.1"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVES:<\/jats:title>\n            <jats:p>To describe the prevalence, associated factors, and clinical impact of an initial negative herpes simplex virus (HSV) polymerase chain reaction (PCR) in critically ill patients with PCR-proven HSV encephalitis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DESIGN:<\/jats:title>\n            <jats:p>Retrospective multicenter study from 2007 to 2017.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SETTING:<\/jats:title>\n            <jats:p>Forty-seven French ICUs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PATIENTS:<\/jats:title>\n            <jats:p>Critically ill patients admitted to the ICU with possible\/probable acute encephalitis and a positive cerebrospinal fluid (CSF) PCR for HSV.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>INTERVENTIONS:<\/jats:title>\n            <jats:p>None.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n            <jats:p>We included 273 patients with a median Glasgow Coma Scale score of 9 (6\u201312) at ICU admission. CSF HSV PCR was negative in 11 cases (4%), exclusively in lumbar punctures (LPs) performed less than 4 days after symptoms onset. Patients with an initial negative PCR presented with more frequent focal neurologic signs (4\/11 [36.4%] vs 35\/256 [13.7%]; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.04) and lower CSF leukocytosis (4 cells\/mm<jats:sup>3<\/jats:sup> [3\u201325 cells\/mm<jats:sup>3<\/jats:sup>] vs 52 cells\/mm<jats:sup>3<\/jats:sup> [12\u2013160 cells\/mm<jats:sup>3<\/jats:sup>]; <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.01). An initial negative PCR was associated with an increased delay between LP and acyclovir treatment (3 d [2\u20137 ] vs 0 d [0\u20130 d]; <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.01) and was independently associated with a poor neurologic outcome at hospital discharge (modified Rankin Scale score \u2265 4) (adjusted odds ratio, 9.89; 95% CI, 1.18\u201382.78).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>In severe herpes simplex encephalitis, initial negative CSF HSV PCR occurred in 4% of cases and was independently associated with worse neurologic outcome at hospital discharge. In these patients, a systematic multimodal diagnostic approach including early brain MRI and EEG will help clinicians avoid delayed acyclovir initiation or early inappropriate discontinuation.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ccm.0000000000005485","type":"journal-article","created":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T22:13:39Z","timestamp":1644012819000},"page":"e643-e648","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":33,"title":["Herpes Simplex Virus Encephalitis With Initial Negative Polymerase Chain Reaction in the Cerebrospinal Fluid: Prevalence, Associated Factors, and Clinical Impact*"],"prefix":"10.1097","volume":"50","author":[{"given":"Etienne","family":"de Montmollin","sequence":"first","affiliation":[{"name":"INSERM UMR 1137, Universit\u00e9 de Paris, Sorbonne Paris Cit\u00e9, Paris, France."},{"name":"APHP, Medical and Infectious Diseases Intensive Care Unit, Bichat-Claude Bernard Hospital, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Dupuis","sequence":"additional","affiliation":[{"name":"Medical Intensive Care Unit, Gabriel Montpied University Hospital, Clermont-Ferrand, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Jaquet","sequence":"additional","affiliation":[{"name":"APHP, Medical and Infectious Diseases Intensive Care Unit, Bichat-Claude Bernard Hospital, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamine","family":"Sarton","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, Purpan University Hospital, Toulouse, France."},{"name":"INSERM UPS, Toulouse NeuroImaging Center, Toulouse University, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charline","family":"Sazio","sequence":"additional","affiliation":[{"name":"Medical Intensive Care Unit, Bordeaux University Hospital, Bordeaux, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Susset","sequence":"additional","affiliation":[{"name":"Polyvalent Intensive Care Unit, M\u00e9tropole Savoie Hospital, Chambery, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Conrad","sequence":"additional","affiliation":[{"name":"Medical Intensive Care Unit, Central Hospital, Nancy University Hospital, Nancy, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Argaud","sequence":"additional","affiliation":[{"name":"Medical Intensive Care Unit, Edouard Herriot University Hospital, Lyon, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Demeret","sequence":"additional","affiliation":[{"name":"APHP, Neurologic Intensive Care Unit, Pitie\u0301\u2013Salpe\u0302trie\u0300re University Hospital, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Marc","family":"Tadi\u00e9","sequence":"additional","affiliation":[{"name":"Infectious Diseases and Intensive Care Unit, Pontchaillou University Hospital, Rennes, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Barbier","sequence":"additional","affiliation":[{"name":"Medical Intensive Care Unit, Orl\u00e9ans Regional Hospital, Orle\u0301ans, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Wolff","sequence":"additional","affiliation":[{"name":"Neuro Intensive Care Unit, Groupe Hospitalo-Universitaire, Paris-NeuroSciences, H\u00f4pital Sainte-Anne, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Timsit","sequence":"additional","affiliation":[{"name":"INSERM UMR 1137, Universit\u00e9 de Paris, Sorbonne Paris Cit\u00e9, Paris, France."},{"name":"APHP, Medical and Infectious Diseases Intensive Care Unit, Bichat-Claude Bernard Hospital, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Visseaux","sequence":"additional","affiliation":[{"name":"INSERM UMR 1137, Universit\u00e9 de Paris, Sorbonne Paris Cit\u00e9, Paris, France."},{"name":"Virology Laboratory, Bichat-Claude Bernard Hospital, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Sonneville","sequence":"additional","affiliation":[{"name":"APHP, Medical and Infectious Diseases Intensive Care Unit, Bichat-Claude Bernard Hospital, Paris, France."},{"name":"INSERM UMR 1148, Team 6, Universit\u00e9 de Paris, Sorbonne Paris Cit\u00e9, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the ENCEPHALITICA Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,2,3]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1473-3099(10)70222-X","article-title":"Causes of encephalitis and differences in their clinical presentations in England: A multicentre, population-based prospective study.","volume":"10","author":"Granerod","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"773","DOI":"10.14740\/jocmr4025","article-title":"Herpes simplex virus encephalitis: Patterns of epidemiology and outcomes of patients admitted to the Intensive Care Unit in Texas, 2008 - 2016.","volume":"11","author":"Oud","year":"2019","journal-title":"J Clin Med Res"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00134-019-05684-0","article-title":"Functional outcomes in adult patients with herpes simplex encephalitis admitted to the ICU: A multicenter cohort study.","volume":"45","author":"Jaquet","year":"2019","journal-title":"Intensive Care Med"},{"key":"R4-20250502","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1086\/341405","article-title":"Outcome of and prognostic factors for herpes simplex encephalitis in adult patients: Results of a multicenter study.","volume":"35","author":"Raschilas","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/infdis\/171.4.857","article-title":"Diagnosis of herpes simplex encephalitis: Application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.","volume":"171","author":"Lakeman","year":"1995","journal-title":"J Infect Dis"},{"key":"R7-20250502","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cmi.2019.11.016","article-title":"Diagnostic test accuracy of the BioFire\u00ae FilmArray\u00ae meningitis\/encephalitis panel: A systematic review and meta-analysis.","volume":"26","author":"Tansarli","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"R8-20250502","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1086\/339550","article-title":"Patients with suspected herpes simplex encephalitis: Rethinking an initial negative polymerase chain reaction result.","volume":"34","author":"Weil","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R9-20250502","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1086\/589747","article-title":"The management of encephalitis: Clinical practice guidelines by the Infectious Diseases Society of America.","volume":"47","author":"Tunkel","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R10-20250502","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.medmal.2017.01.005","article-title":"Guidelines on the management of infectious encephalitis in adults.","volume":"47","author":"Stahl","year":"2017","journal-title":"Med Mal Infect"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000005485","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T18:02:46Z","timestamp":1746208966000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000005485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,3]]},"references-count":9,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000005485","relation":{},"ISSN":["0090-3493"],"issn-type":[{"value":"0090-3493","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,3]]}}}